
Laura Lynne Stockton
Examiner (ID: 6934)
| Most Active Art Unit | 1626 |
| Art Unit(s) | 2899, 1613, 1201, 1614, 1646, 1626 |
| Total Applications | 3246 |
| Issued Applications | 2197 |
| Pending Applications | 344 |
| Abandoned Applications | 753 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8056231
[patent_doc_number] => 20120077853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/309452
[patent_app_country] => US
[patent_app_date] => 2011-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9868
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20120077853.pdf
[firstpage_image] =>[orig_patent_app_number] => 13309452
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/309452 | Human protein tyrosine phosphatase inhibitors and methods of use | Nov 30, 2011 | Issued |
Array
(
[id] => 8173739
[patent_doc_number] => 20120108576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'THIAZOLE COMPOUNDS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/307761
[patent_app_country] => US
[patent_app_date] => 2011-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34476
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20120108576.pdf
[firstpage_image] =>[orig_patent_app_number] => 13307761
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/307761 | THIAZOLE COMPOUNDS AND METHODS OF USE | Nov 29, 2011 | Abandoned |
Array
(
[id] => 8056485
[patent_doc_number] => 20120077984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'Process For Preparing Epothilone Derivatives By Selective Catalytic Epoxidation'
[patent_app_type] => utility
[patent_app_number] => 13/308046
[patent_app_country] => US
[patent_app_date] => 2011-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4330
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20120077984.pdf
[firstpage_image] =>[orig_patent_app_number] => 13308046
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/308046 | Process for preparing epothilone derivatives by selective catalytic epoxidation | Nov 29, 2011 | Issued |
Array
(
[id] => 8056511
[patent_doc_number] => 20120077985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'PROCESS FOR PRODUCING FUSED IMIDAZOLE COMPOUND, REFORMATSKY REAGENT IN STABLE FORM, AND PROCESS FOR PRODUCING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/305411
[patent_app_country] => US
[patent_app_date] => 2011-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 40187
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20120077985.pdf
[firstpage_image] =>[orig_patent_app_number] => 13305411
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/305411 | Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same | Nov 27, 2011 | Issued |
Array
(
[id] => 9149259
[patent_doc_number] => 20130303782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'PROCESS FOR PREPARATION OF ALBENDAZOLE'
[patent_app_type] => utility
[patent_app_number] => 13/989497
[patent_app_country] => US
[patent_app_date] => 2011-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1558
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13989497
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/989497 | PROCESS FOR PREPARATION OF ALBENDAZOLE | Nov 22, 2011 | Abandoned |
Array
(
[id] => 9149258
[patent_doc_number] => 20130303781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'PROCESS FOR PREPARATION OF TRICLABENDAZOLE'
[patent_app_type] => utility
[patent_app_number] => 13/989147
[patent_app_country] => US
[patent_app_date] => 2011-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1917
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13989147
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/989147 | PROCESS FOR PREPARATION OF TRICLABENDAZOLE | Nov 22, 2011 | Abandoned |
Array
(
[id] => 9149257
[patent_doc_number] => 20130303780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'PROCESS FOR THE PREPARATION OF 2-ARYLTHIAZOLE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/883843
[patent_app_country] => US
[patent_app_date] => 2011-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1700
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13883843
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/883843 | PROCESS FOR THE PREPARATION OF 2-ARYLTHIAZOLE DERIVATIVES | Nov 2, 2011 | Abandoned |
Array
(
[id] => 8173773
[patent_doc_number] => 20120108583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'Tricyclic Compounds As mPGES-1 Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/283786
[patent_app_country] => US
[patent_app_date] => 2011-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71338
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20120108583.pdf
[firstpage_image] =>[orig_patent_app_number] => 13283786
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/283786 | Tricyclic compounds as mPGES-1 inhibitors | Oct 27, 2011 | Issued |
Array
(
[id] => 9212078
[patent_doc_number] => 20140011255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'Biotin Derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/881518
[patent_app_country] => US
[patent_app_date] => 2011-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16729
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13881518
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/881518 | Biotin derivatives | Oct 27, 2011 | Issued |
Array
(
[id] => 7784747
[patent_doc_number] => 20120046303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-23
[patent_title] => 'BENZIMIDAZOLE POLY(ADP RIBOSE)POLYMERASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/282826
[patent_app_country] => US
[patent_app_date] => 2011-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24347
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20120046303.pdf
[firstpage_image] =>[orig_patent_app_number] => 13282826
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/282826 | BENZIMIDAZOLE POLY(ADP RIBOSE)POLYMERASE INHIBITORS | Oct 26, 2011 | Abandoned |
Array
(
[id] => 8095987
[patent_doc_number] => 20120083608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-05
[patent_title] => 'PROCESS FOR THE PREPARATION OF [4-(2-CHLORO-4- METHOXY-5-METHYLPHENYL)-5-METHYL-THIAZOLO-2-YL]-[2-CYCLOPROPYL-1-(3-FLUORO-4-METHYLPHENYL)-ETHYL]-AMINE'
[patent_app_type] => utility
[patent_app_number] => 13/282721
[patent_app_country] => US
[patent_app_date] => 2011-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1511
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20120083608.pdf
[firstpage_image] =>[orig_patent_app_number] => 13282721
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/282721 | Process for the preparation of [4-(2-chloro-4-methoxy-5-methylphenyl)-5-methyl-thiazolo-2-yl]-[2-cyclopropyl-1-(3-fluoro-4-methylphenyl | Oct 26, 2011 | Issued |
Array
(
[id] => 8896930
[patent_doc_number] => 08476452
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-02
[patent_title] => 'Process for preparing 1,2-benzoisothiazoline-3-one'
[patent_app_type] => utility
[patent_app_number] => 13/281600
[patent_app_country] => US
[patent_app_date] => 2011-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1754
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13281600
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/281600 | Process for preparing 1,2-benzoisothiazoline-3-one | Oct 25, 2011 | Issued |
Array
(
[id] => 9704135
[patent_doc_number] => 08829200
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-09
[patent_title] => 'Benzimidazole inhibitors of leukotriene production'
[patent_app_type] => utility
[patent_app_number] => 13/281685
[patent_app_country] => US
[patent_app_date] => 2011-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13990
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13281685
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/281685 | Benzimidazole inhibitors of leukotriene production | Oct 25, 2011 | Issued |
Array
(
[id] => 7778659
[patent_doc_number] => 20120041041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => '5-HYDROXY-BENZOTHIAZOLE DERIVATIVES HAVING BETA-2-ADRENORECEPTOR AGONIST ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 13/278636
[patent_app_country] => US
[patent_app_date] => 2011-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8313
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20120041041.pdf
[firstpage_image] =>[orig_patent_app_number] => 13278636
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/278636 | 5-HYDROXY-BENZOTHIAZOLE DERIVATIVES HAVING BETA-2-ADRENORECEPTOR AGONIST ACTIVITY | Oct 20, 2011 | Abandoned |
Array
(
[id] => 8199558
[patent_doc_number] => 20120122943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'Melampomagnolide B Derivatives as Antileukemic and Cytotoxic Agents'
[patent_app_type] => utility
[patent_app_number] => 13/279038
[patent_app_country] => US
[patent_app_date] => 2011-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 21084
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20120122943.pdf
[firstpage_image] =>[orig_patent_app_number] => 13279038
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/279038 | Melampomagnolide B derivatives as antileukemic and cytotoxic agents | Oct 20, 2011 | Issued |
Array
(
[id] => 8936671
[patent_doc_number] => 20130186468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-25
[patent_title] => 'PHOTOELECTRIC CONVERSION DEVICE AND PHOTOELECTRIC CONVERSION DEVICE DYE, AND COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 13/876618
[patent_app_country] => US
[patent_app_date] => 2011-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22914
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13876618
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/876618 | Photoelectric conversion device and photoelectric conversion device dye, and compound | Sep 26, 2011 | Issued |
Array
(
[id] => 10920720
[patent_doc_number] => 20140323741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'DYES FOR LABELLING MOLECULAR LIGANDS'
[patent_app_type] => utility
[patent_app_number] => 14/346657
[patent_app_country] => US
[patent_app_date] => 2011-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11368
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14346657
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/346657 | Dyes for labelling molecular ligands | Sep 22, 2011 | Issued |
Array
(
[id] => 7733403
[patent_doc_number] => 20120015911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'METHOD AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/237576
[patent_app_country] => US
[patent_app_date] => 2011-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 123298
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20120015911.pdf
[firstpage_image] =>[orig_patent_app_number] => 13237576
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/237576 | Method and compositions for treating amyloid-related diseases | Sep 19, 2011 | Issued |
Array
(
[id] => 9127410
[patent_doc_number] => 08575361
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-05
[patent_title] => 'Tetrahydronaphthalene derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/227047
[patent_app_country] => US
[patent_app_date] => 2011-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18707
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13227047
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/227047 | Tetrahydronaphthalene derivatives | Sep 6, 2011 | Issued |
Array
(
[id] => 7808032
[patent_doc_number] => 20120058986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'DI-AZETIDINYL DIAMIDE AS MONOACYLGLYCEROL LIPASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/224654
[patent_app_country] => US
[patent_app_date] => 2011-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24519
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058986.pdf
[firstpage_image] =>[orig_patent_app_number] => 13224654
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/224654 | DI-AZETIDINYL DIAMIDE AS MONOACYLGLYCEROL LIPASE INHIBITORS | Sep 1, 2011 | Abandoned |